Seth Eisenberg, ASN, RN, OCN, BMTCN

home / authors / seth-eisenberg-rn-adn-ocn

Articles

Seth Eisenberg

Seth Eisenberg Compares the Effectiveness of Plastic-Backed Pads Vs The Splashblocker in Reducing Toilet Aerosols

Seth Eisenberg, ASN, RN, OCN, BMTCN
May 18th 2023

Seth Eisenberg, ASN, RN, OCN, BMTCN, discusses his research comparing plastic-backed pads and the Splashblocker.

Seth Eisenberg Discusses a Multilayered Approach to Chemotherapy Safety

Seth Eisenberg Discusses a Multilayered Approach to Chemotherapy Safety

Seth Eisenberg, ASN, RN, OCN, BMTCN
January 16th 2015

Seth Eisenberg, RN, ADN, OCN, professional practice coordinator, infusion services, Seattle Cancer Care Alliance, discusses using a multilayered approach to chemotherapy safety.

Seth Eisenberg Discusses the Importance of Total Chemotherapy Safety

Seth Eisenberg Discusses the Importance of Total Chemotherapy Safety

Seth Eisenberg, ASN, RN, OCN, BMTCN
August 28th 2014

Seth Eisenberg, RN, ADN, OCN, professional practice coordinator, infusion services, Seattle Cancer Care Alliance, discusses the importance of practicing total chemotherapy safety when nurses handle chemotherapy.

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.